IRF1 |
Microglia/macrophage |
IFN-γ |
Interact with MyD88. |
Regulate TLR-mediated expression of pro-inflammatory genes. |
66,67,68,69,70 |
IRF2 |
Any cells |
IFN-γ and virus |
Compete with IRF1 for DNA binding sites. |
Activator of H4 gene, VCAM-1, and TLR9 gene; augment LPS induced IL-1, IL-6, IL-12, and IFN-γ secretion; repress the transcriptional activation of the IFN-b gene. |
71,72,73,74,75,76 |
IRF3 |
Ependymal cells and choroid plexus |
Molecules mediated by dsRNA and dsDNA |
Be the crucial transcription factor in non-MyD88 pathway. |
Alter the microglial activation phenotype from M1 to M2; transactivate the IFN-b, CXCL10, CCL5, ISG56, IFIT1, arginase II and RIG-Ilike eceptors gene. |
77,78 |
IRF4 |
Bone marrow-derived macrophages/microglia |
Different mitogenic stimuli |
Through IL-4 signaling; mediated by the transcription factor signal transducer and activator of Stat6. |
Control M2 polarization; regulate MHC-II, Ciita, Cyp1b1, and Il1rn genes. |
79,80,81,82 |
IRF5 |
Microglia B cells, dendritic cells, macrophages/microglia |
Type I IFN and viral infection |
Decrease TLR3-, TLR4-, and TLR9-dependent induction of TNFα and I IFN. |
Regulate host immunity against extracellular pathogens, DNA damage-induced apoptosis, death receptor signaling, and classic macrophage polarization. |
83,84 |
IRF7 |
Microglia/macrophages |
Toll-like receptor 4 signaling |
Suppress the activation of STAT1. |
Involved in demyelination. |
85 |
IRF8 |
Microglia |
Type I IFN |
Activate gene expression that transforms microglia into a reactive phenotype. |
Increase levels of Iba1, CD206, CD45, CD11b and F4/80 and F4/80; decrease levels of the chemokine receptors CCR2, CCR5 and CX3CR1. |
86,87,88,90,91 |